72.03
-0.48 (-0.66%)
| Penutupan Terdahulu | 72.51 |
| Buka | 72.71 |
| Jumlah Dagangan | 305,331 |
| Purata Dagangan (3B) | 461,101 |
| Modal Pasaran | 2,093,038,208 |
| Harga / Jualan (P/S) | 10.15 |
| Harga / Buku (P/B) | 117.06 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 5 Nov 2025 |
| Margin Keuntungan | -52.34% |
| Margin Operasi (TTM) | -40.96% |
| EPS Cair (TTM) | -3.12 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 11.30% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 585.48% |
| Nisbah Semasa (MRQ) | 3.36 |
| Aliran Tunai Operasi (OCF TTM) | -68.09 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -44.94 M |
| Pulangan Atas Aset (ROA TTM) | -11.43% |
| Pulangan Atas Ekuiti (ROE TTM) | -186.68% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Bercampur |
| Medical Devices (Global) | Bercampur | Bercampur | |
| Stok | Establishment Labs Holdings Inc | Menurun | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -0.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -0.5 |
| Purata | 0.88 |
|
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing silicone-filled breast and body shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 10.75% |
| % Dimiliki oleh Institusi | 106.06% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 90.00 (Mizuho, 24.95%) | Beli |
| Median | 84.50 (17.31%) | |
| Rendah | 75.00 (Citigroup, 4.12%) | Pegang |
| Purata | 83.33 (15.69%) | |
| Jumlah | 5 Beli, 1 Pegang | |
| Harga Purata @ Panggilan | 72.75 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Needham | 12 Jan 2026 | 84.00 (16.62%) | Beli | 66.76 |
| 10 Dec 2025 | 84.00 (16.62%) | Beli | 72.46 | |
| BTIG | 31 Dec 2025 | 86.00 (19.39%) | Beli | 72.88 |
| 14 Nov 2025 | 81.00 (12.45%) | Beli | 63.99 | |
| Canaccord Genuity | 17 Dec 2025 | 85.00 (18.01%) | Beli | 74.71 |
| 06 Nov 2025 | 72.00 (-0.04%) | Beli | 64.91 | |
| JP Morgan | 17 Dec 2025 | 80.00 (11.06%) | Beli | 74.71 |
| 06 Nov 2025 | 71.00 (-1.43%) | Beli | 64.91 | |
| Mizuho | 17 Dec 2025 | 90.00 (24.95%) | Beli | 74.71 |
| 06 Nov 2025 | 85.00 (18.01%) | Beli | 64.91 | |
| Citigroup | 11 Dec 2025 | 75.00 (4.12%) | Pegang | 72.72 |
| Papar semua | ||||
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 12 Jan 2026 | Pengumuman | Establishment Labs Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025 |
| 31 Dec 2025 | Pengumuman | Establishment Labs to Present at 44th Annual J.P. Morgan Healthcare Conference |
| 29 Dec 2025 | Pengumuman | Establishment Labs Submits to FDA for Approval of Motiva Implants in Breast Reconstruction |
| 07 Nov 2025 | Pengumuman | Establishment Labs to Present at Jefferies London Healthcare Conference |
| 05 Nov 2025 | Pengumuman | Establishment Labs Reports Third Quarter 2025 Financial Results |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |